Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Copper Miners ETF (COPX) vs Eli Lilly And Co (LLY) Price & Performance

Global X Copper Miners ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Global X Copper Miners ETF vs Eli Lilly And Co — how do they compare? Global X Copper Miners ETF trades at $78.24, while Eli Lilly And Co trades at $1,153.92 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while Global X Copper Miners ETF pays none. Which is the better fit depends on your goals.

COPXLLY
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$95.70$1.24K
52-Week Low
$42.75$625.65
Market Cap
$1.03T
Enterprise Value
$1.07T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Copper Miners ETF

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,185.08, down slightly (-0.29%) on the day, with a strong bullish technical signal from moving averages. The company demonstrates exceptional fundamental strength, with revenue surging to $65.18B in 2025 and a net income margin of 34.99%. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive, with a consensus price target of $1,360.

The outlook for LLY remains robust, driven by its dominant position in the high-growth weight loss and Alzheimer's drug markets. Key opportunities include continued revenue expansion and pipeline advancements. Primary risks involve intensifying competition, particularly from Novo Nordisk's obesity pill, and the stock's premium valuation multiples, which demand sustained high growth to justify.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X Copper Miners ETF

COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.

Read more on COPX

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY